Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology

The new coronavirus SARS-CoV-2, which gives rise to the highly contagious COVID-19 disease, has caused a pandemic that is overwhelming health care systems worldwide. Affected patients have been reported to have a heightened inflammatory state that increases their thrombotic risk. However, there is v...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivas, David, Roldán, Vanessa, Esteve-Pastor, María Asunción, Roldán, Inmaculada, Tello-Montoliu, Antonio, Ruiz-Nodar, Juan Miguel, Cosín-Sales, Juan, Gámez, José María, Consuegra, Luciano, Ferreiro, José Luis, Marín, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303617/
https://www.ncbi.nlm.nih.gov/pubmed/32694078
http://dx.doi.org/10.1016/j.rec.2020.04.025
Descripción
Sumario:The new coronavirus SARS-CoV-2, which gives rise to the highly contagious COVID-19 disease, has caused a pandemic that is overwhelming health care systems worldwide. Affected patients have been reported to have a heightened inflammatory state that increases their thrombotic risk. However, there is very scarce information on the management of thrombotic risk, coagulation disorders, and anticoagulant therapy. In addition, the situation has also greatly influenced usual care in patients not infected with COVID-19. This article by the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology aims to summarize the available information and to provide a practical approach to the management of antithrombotic therapy.

Ejemplares similares